Introduction
============

Chronic obstructive pulmonary disease (COPD) is a disease the incidence of which continues to increase.[@b1-copd-7-819] It is the leading cause of death worldwide, with a rising mortality rate, and, by the year 2020, it is expected that this will be the fifth leading condition among conditions with a high socioeconomic burden to society.[@b2-copd-7-819] The disease course is characterized by a progressive reduction in pulmonary function and recurrent exacerbations that may lead to acute respiratory failure, requiring intensive care unit (ICU) admissions for ventilation support, and the consumption of large ICU resources. The prognosis of these patients, particularly those who require invasive mechanical ventilation (IMV), is poor. The in-hospital mortality rate from COPD exacerbation is between 8% and 25%,[@b3-copd-7-819]--[@b5-copd-7-819] and the 1-year mortality rate after discharge from the ICU increases to between 35% and 48%.[@b5-copd-7-819],[@b6-copd-7-819] Prognostic factors for in-hospital mortality and long-term outcomes have been identified to assist in clinical decision making and ICU management for the better utilization of medical resources.[@b3-copd-7-819],[@b4-copd-7-819],[@b7-copd-7-819],[@b8-copd-7-819]

To the best of our knowledge, mortality due to COPD exacerbation in the ICU and its predictors has not yet been reported by the Kingdom of Saudi Arabia. Therefore, we present a retrospective cohort of COPD patients admitted to our ICU, their outcomes in terms of mortality rates, and predictors of hospital mortality.

Methods
=======

The medical records of all patients admitted to the ICU in King Abdulaziz National Guard hospital in Al-Hasa, Saudi Arabia with a diagnosis of COPD during the period January 1, 2006 to July 31, 2011 were actively reviewed. Admission with acute respiratory failure secondary to COPD exacerbation was also included. COPD was defined according to the Global Initiative for Obstructive Lung Disease,[@b9-copd-7-819] and it was identified from the patient's premorbid pulmonary function testing results; if this information was unavailable, data were gathered from the patient history with compatible physical examination findings, which are documented in each patient's chart. Exacerbation was defined by the presence of at least two of the three following symptoms: dyspnea, cough, and increasing of sputum purulence. Patients were excluded from the study if they had postoperative status, trauma, or if they were COPD patients admitted for diagnoses other than exacerbation.

The following data were extracted from the patient charts: demographic characteristics, comorbidities, APACHE II score, smoking history, exacerbation causes, Glasgow Coma Scale on admission, arterial blood gas upon admission and discharge, use of invasive and noninvasive mechanical ventilation, and the outcome results of each admission. The outcome variables include the following: ICU mortality, hospital mortality, duration of mechanical ventilation, tracheotomy, cardiopulmonary arrest, and the development of acute renal failure during hospital admission. We analyzed the first ICU admissions per patient hospitalization. The research proposal was approved by the King Abdullah International Medical Research Center (KAIMRC), Al-Hasa, Saudi Arabia.

Ventilation management during the ICU stay was initiated based on the judgment of the attending staff physician; however, noninvasive positive pressure ventilation (NIPPV) was used when applicable. All patients received standard treatment for COPD exacerbation, which includes bronchodilators, systemic corticosteroids, and appropriate antibiotics. Weaning from mechanical ventilators was performed according to the weaning protocol.[@b10-copd-7-819] Sedation, analgesia, and blood sugar management were provided as per their respective protocol in our ICU.[@b11-copd-7-819]

Statistical analysis
--------------------

Descriptive results were presented as the mean ± standard deviation for all quantitative variables (eg, age) if normally distributed, and the median with minimum and maximum values was presented if the data were not normally distributed. Numbers (percentages) were reported for all qualitative variables (eg, sex). New binary variable status at discharge (alive versus dead) were created based on ICU or hospital mortality to compare all of the demographic and clinical characteristics between the two groups. Univariate analysis was performed using an independent samples *t*-test, or the Mann--Whitney U tests, if appropriate, for all quantitative variables. The Pearson chi-squared test, or the Fisher's exact test, if appropriate, for all qualitative variables was also performed to compare patients' mortality rates.

Multiple logistic regression models were built to identify the significant independent factors associated with survival. To build the model, a purposeful selection method was used to select a subset of covariates that were considered to be clinically important, adjusting for confounders and statistical significance. A purposeful selection of covariates begins with a multivariate model that contains all variables that are significant in the bivariate analysis at the 20%--25% level, as well as any other variables not selected with this criterion, but judged to be of clinical importance. We used *P*-values from the Wald tests of the individual coefficient to identify covariates that might be deleted from the model, and the *P*-values of the partial likelihood ratio test confirmed that the deleted covariates were not significant. Following the fitting of the reduced model, we assessed whether the removal of the covariate produced an "important" change (approximately 20%) in the coefficient of the variables remaining in the model. The final model was assessed using the goodness-of-fit test to see if the model fit the data well. An adjusted odds ratio and a 95% confidence interval (CI) were reported for each independent factor. Two-tailed *P*-values \<0.05 were considered statistically significant. All statistical analyses were performed using SPSS (Statistical Package for the Social Sciences version 19.0, IBM Corporation, Armonk, NY).

Results
=======

Overall, 178 COPD patients were admitted to the adult ICU over the study period, and 59 patients were excluded because they were not hospitalized based on COPD exacerbation. Thus, 119 patients were included in the study population.

The patients' characteristics and features are listed in [Table 1](#t1-copd-7-819){ref-type="table"}. The mean age was 72 ± 13.3 years; one-third of participants were more than 65 years old, and the majority were male. The mean APACHE II score was 17.75 ± 6.3. Sixty-six patients (55%) had two or more comorbidities, of which nearly half were attributable to type 2 diabetes and hypertension. A total of 86% of the patients had infective exacerbation of COPD. One-third of the patients received IMV for a median duration of 2.5 days. Sixty-six (55%) patients received NIPPV as the initial treatment, but eight patients failed during its use and received IMV ([Table 1](#t1-copd-7-819){ref-type="table"}).

The hospital mortality rate was 11%, and seven of these cases (6%) died in the ICU. The median ICU and hospital stays were 3 and 9 days, respectively. Nine percent of the patients received a tracheostomy, and 48% were discharged home with a home oxygen device supplement. Few patients had severe complications related to the severity of COPD exacerbation, such as cardiopulmonary arrest (3%) and acute renal failure (5%) ([Table 2](#t2-copd-7-819){ref-type="table"}).

Patients who died were significantly more likely to have had lower Glasgow Coma Scale scores; they were also more likely to have developed acute renal failure, had a tracheostomy, experienced cardiopulmonary arrest, and to have been smokers at the time of the study. The duration of IMV was significantly higher among those who died versus those who were alive, with an associated *P*-value of 0.002 ([Table 3](#t3-copd-7-819){ref-type="table"}).

The multiple logistic regression model identified that Glasgow Coma Scale scores, the development of acute renal failure, and being a smoker were significant independent prognostic factors associated with survival ([Table 4](#t4-copd-7-819){ref-type="table"}). Patients aged 65 or older were included in the model. The results of the regression analysis showed that age \> 65 (odds ratio \[OR\] = 0.064, 95% CI: 0.003--1.44), Glasgow Coma Scale score ≤ 10 (OR = 1.24, 95% CI: 1.042--1.76), the development of acute renal failure (OR = 0.026, 95% CI: 0.002--0.308), and current smoking status (OR = 0.062, 95% CI: 0.01--0.389) were the most significant contributing factors leading to patient mortality.

Discussion
==========

In our study, we found that the hospital mortality rates of COPD patients admitted with respiratory failure due to COPD exacerbation was 11% and ICU mortality rate was 6%. The overall hospital mortality was lower than mortality rates reported in other studies. In Spain, Raurich et al[@b4-copd-7-819] reported an in-hospital mortality of 26% among COPD patients who were admitted to the ICU and received IMV due to COPD exacerbation. This was attributed to prolonged IMV use, as well as more days spent in ICU and hospitalization. Ai-Ping et al[@b3-copd-7-819] reported a 24% in-hospital mortality rate during ICU admission in 2004. Ninety percent of their cohort received mechanical intubations, which explains the magnitude of these higher mortality rates. This could be explained by several reasons. First, the early use of noninvasive mechanical ventilation was associated with a high success rate (84%). Moreover, noninvasive MV has been shown to improve patient outcomes and avoid endotracheal intubation.[@b8-copd-7-819],[@b12-copd-7-819],[@b13-copd-7-819] Second, our population sample had a lower APACHE II score compared to others. Third, fewer patients required mechanical ventilation and prolonged ICU and hospital stays, which other studies have demonstrated to increase in-hospital mortality.[@b13-copd-7-819],[@b14-copd-7-819]

Multiple risk factors were found to be associated with early ICU mortality. A low Glasgow Coma Scale score equal to or less than ten, intubation, tracheostomy, cardiopulmonary arrest, the development of acute renal failure during ICU admission, and status as a current smoker were found to be associated with increased hospital mortality; this has been described in the literature. Afessa et al[@b7-copd-7-819] found that previous intubation, age, duration of hospital stay, and APACHE II score were significantly correlated with higher mortality in COPD patients that were admitted to the ICU with exacerbation. Interestingly, our study identified the presence of acute renal failure as a risk factor for increasing mortality, which was not known before. This may elucidate the importance of intravenous fluid and use of diuretics in critical care.

Of particular interest is that 37% of the patients were females who had never smoked. The development of COPD among this population has been attributed to the extensive use of incense burners, especially among Saudi women, who use them for traditional perfumes.[@b14-copd-7-819] Furthermore, the problem of the misdiagnosis of asthma and COPD is common, considering that one-fifth of elderly asthma patients are misdiagnosed as having COPD.[@b15-copd-7-819]

Our study has several limitations related to both its design and it being a single-center study. We had no information related to the functional status of the patients and their compliance with treatment. Although our ICU has a standardized protocol for weaning IMV, alternative medical plans and NIPPV treatment were most likely determined by the individual physician's preference, which may have affected the outcomes.

In conclusion, COPD patients admitted to the ICU due to COPD exacerbation have a good chance of surviving until hospital discharge. Multiple independent risk factors, including the development of acute renal failure, low consciousness level, and a patient's status of being a current smoker significantly increase in-hospital mortality. Further study is required to identify the long-term survival rates of this population.
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###### 

Demographic and clinical characteristics of patients

  Factor                                            Results
  ------------------------------------------------- ---------------
  Total patients, n                                 119
  Age (years), mean ± SD                            72 ± 13
  Female, n (%)                                     44 (37)
  APACHE II score, mean ± SD                        17.75 ± 6.3
  **Comorbidity**                                   
  Diabetes, n (%)                                   95 (80)
  Hypertension, n (%)                               101 (85)
  Coronary artery diseases, n (%)                   52 (44)
  Chronic renal failure, n (%)                      21 (18)
  Malignancy, n (%)                                 12 (10)
  Anticoagulation, n (%)                            33 (28)
  Exsmoker, n (%)                                   38 (32)
  **Causes of exacerbation**                        
  Infection, n (%)                                  102 (86)
  Noninfection, n (%)                               17 (14)
  **Spirometry**                                    
  FEV~1~ (%), mean ± SD                             44.89 ± 16.2
  FEV~1~/FVC (%), mean ± SD                         49.87 ± 11.25
  **Arterial blood gas on admission**               
  pH, mean ± SD                                     7.26 ± 0.12
  PCO~2~ (mmHg), mean ± SD                          65.71 ± 20.78
  **Conscious level on admission**                  
  Glasgow Coma Scale ≤ 10, n (%)                    19 (16)
  **Ventilatory management**                        
  Patients received IMV, n (%)                      39 (33)
  Duration of MV (days), median (range)             2.5 (1--42)
  Patients received NIPPV, n (%)                    66 (55)
  Patients intubated after failing NIPPV, n (%)     8 (12)
  Patients received NIPPV after extubation, n (%)   19 (16)

**Abbreviations:** APACHE II, Acute Physiology and Chronic Health Evaluation II; FEV~1~, forced expiratory volume in first second; FVC, forced vital capacity; IMV, invasive mechanical ventilation; MV, mechanical ventilation; n, number; NIPPV, noninvasive positive pressure ventilation; PCO~2~, partial pressure of carbon dioxide.

###### 

The outcomes of COPD patients admitted to the ICU

  Factor                                          Results
  ----------------------------------------------- -----------
  ICU mortality, n (%)                            7 (6)
  Hospital mortality, n (%)                       13 (11)
  ICU stay (days), median (range)                 3 (1--40)
  Hospital stay (days), median (range)            9 (2--43)
  Post-ICU hospital stay (days), median (range)   4 (1--40)
  Tracheotomy, n (%)                              11 (9)
  Cardiopulmonary arrest, n (%)                   3 (3)
  Acute renal failure, n (%)                      6 (5)
  Home O~2~ device on discharge, n (%)            57 (48)

**Abbreviations:** COPD, chronic obstructive pulmonary disease; ICU, Intensive Care Unit; n, number.

###### 

Predictors of hospital mortality

  Factor                                  Nonsurvival   Survival    *P*-value[§](#tfn5-copd-7-819){ref-type="table-fn"}
  --------------------------------------- ------------- ----------- -----------------------------------------------------
  Duration of MV (days), median (range)   6 (1--42)     2 (1--25)   0.002[ψ](#tfn4-copd-7-819){ref-type="table-fn"}
  Glasgow Coma Scale ≤ 10                 6 (46)        13 (11)     0.006
  Intubation                              9 (69)        31 (27)     0.010
  Tracheotomy                             4 (31)        7 (6)       0.019
  CPR                                     2 (15)        1 (1)       0.031
  ARF                                     4 (31)        2 (2)       0.001
  Currently smoking                       4 (31)        8 (7)       0.026

**Notes:** Results are expressed as number (percentage) unless otherwise specified.

*P*-value has been calculated using the Mann--Whitney U tests;

*P*-value has been calculated using the Pearson Chi-squared test or the Fisher's exact test whenever appropriate, unless otherwise specified.

**Abbreviations:** MV, mechanical ventilation; CPR, cardiopulmonary resuscitation; ARF, acute renal failure.

###### 

The results obtained from the multiple logistic regression analysis, indicating prognostic factors for hospital survival (n = 106 alive versus 13 in-hospital deaths)

  Factor           Adjusted odds ratio   95% CI for adjusted odds ratio   *P*-value
  ---------------- --------------------- -------------------------------- -----------
  Age \>65         0.064                 0.003--1.44                      0.084
  GCS              1.24                  1.042--1.476                     0.015
  ARF              0.026                 0.002--0.308                     0.004
  Current smoker   0.062                 0.010--0.389                     0.003

**Abbreviations:** GCS, Glasgow Coma Scale; ARF, acute renal failure.
